Navigation Links
Lotus Completed R-Bambuterol's Pilot Scale Production for Clinical Trials
Date:8/3/2010

'ExternalLink');" target='_blank' href="http://www.lotuspharma.com">http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. is a growing developer and producer of drugs and a licensed national seller of pharmaceutical items in the PRC. Lotus operates its business through its two controlled entities: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development is focused on the treatment of cerebro-cardiovascular disease, asthma and diabetes. Liang Fang sells drugs directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces of the PRC.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intent," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may," or words or expressions of similar meaning. Such statements are not guarantees of future performance and could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including, but not limited to, changes from anticipated levels of sales, future national or regional economic and competitive and regulatory conditions, changes in relationships with customers, access to capital, increased costs, difficulties in developing and marketing new products, marketing existing products, customer acceptance of existing and new products, the time to get new drugs approved by the State Food and Drug Administration and othe
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lotus Pharmaceuticals Terminates SEDA
2. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
3. Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform
4. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
5. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
6. Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA
7. Lotus Pharmaceuticals Reports Groundbreaking Ceremony
8. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
9. Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
10. Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
11. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... operations in China and ... release financial results for the second quarter of 2014 after ... 2014 (which will be Thursday morning, August 14, 2014 Shanghai ... relations section of the Company,s website at http://www.wuxiapptec.com ...
(Date:7/22/2014)... , July 22, 2014  Pressure ... "Company") and Parabase Genomics ("Parabase"), (together "the ... a strategic research and development agreement (the ... PBI will develop a front-end, sample preparation ... and newborn confirmatory testing process. The sample ...
(Date:7/22/2014)... PORT WASHINGTON, New York , ... Neue Partnerschaft für umfassenden ... gefährlichen Medikamenteneinwirkungen in Österreich    ... führender Anbieter von geschlossenen Transfersystemen (Closed System ... Medikus , einen Vertriebshändler und ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 3Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 4Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... Nov. 1, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering and developing breakthrough treatments for human disease, ... results for the three and nine months ended September ... studies of LX4211 and LX1032 have provided further validation ...
... Corporation (NASDAQ: VOLC ), a leading developer and ... to enhance the treatment of coronary and peripheral artery disease, ... increased 18 percent versus the third quarter of 2010. ... revenues of $85.8 million versus revenues of $72.9 million in ...
Cached Medicine Technology:Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 2Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 3Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 4Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 5Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 6Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 7Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results 8Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 2Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 3Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 4Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 5Volcano Reports 18 Percent Increase in Total Third Quarter Revenues 6
(Date:7/22/2014)... Get Real Health announced today ... (IDF) to provide their patient community with a ... to electronically track their symptoms, medications and other health-related ... also allow those patients and families who want ... data shared with the U.S. Immunodeficiency Network (USIDNET) ...
(Date:7/22/2014)... July 22, 2014 Atreo Services will ... service and support programs and accessories in booth #1423 ... Conference & Technical Exhibition in Chicago, Ill., Aug. 3-6. ... pneumatic tube system carriers as well as its selection ... brand-name hospital tube systems. In addition, representatives will ...
(Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
(Date:7/22/2014)... Dr. Allen Kamrava, colorectal surgeon in Beverly ... new website dedicated to the diagnosis and treatment of ... DrKamrava.com . , “With this new website, I ... trustworthy source for various colorectal conditions ,” says ... colon cancer, hernias, or more, patients will find that ...
(Date:7/22/2014)... FL (PRWEB) July 22, 2014 ... opened registration for multiple upcoming real estate investing workshops ... potentially life-changing events are designed to introduce people to ... in the Canadian market. , A total of 9 ... a period of three weeks. The goal is to ...
Breaking Medicine News(10 mins):Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... Calif., April 1, 2008 MAQUET Cardiovascular,LLC ... infringement complaints,in the United States International Trade ... District of Northern California against Terumo Corporation,and ... that,Terumo infringes two MAQUET U.S. patents through ...
... have found that community health center-trained family physicians were ... non-community health center-trained counterparts (64 percent versus 37 percent), ... of Family Medicine. The news comes on the heels ... Program that there is an increased interest in family ...
... College of Cardiology during,ceremonies at the 57th Annual ... CHICAGO, April 1, 2008 Robert O. Bonow, ... Northwestern Memorial Hospital, and Goldberg Distinguished Professor of,Northwestern ... the,American College of Cardiology (ACC) as Master of ...
... 1, 2008 Faced with shrinking,staffs and less ... time serving the hospital marketplace. As their time,to ... for the,pharma industry are turning to other decision-makers ... formularies, according to research from benchmarking,leader Best Practices, ...
... for Heightened Autism Awareness among Hispanic Community as Fewer ... Receiving Diagnosis and Support, ... its services for individuals living with autism, among the,vast array of ... ones., Over the last 20 years, Easter Seals has seen ...
... Co-Chairs and Leading Grassroots Autism Association Push,for Services ... The United,Nations has designated April 2 as World ... Autism Society of America, the World Autism,Organization and ... Research and Education (C.A.R.E.), Rep. Chris Smith and ...
Cached Medicine News:Health News:MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo 2Health News:Want docs to treat the underserved? Make sure they train at community health centers 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 2Health News:Robert Bonow, MD Honored for Outstanding Service by the American College of Cardiology 3Health News:Effectively Influencing the Hospital Marketplace to Win a Place on Formularies 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 2Health News:Easter Seals Notes April's Autism Awareness Month to Highlight Services Available to Families Living With Autism 3Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 2Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 3
Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix...
The latest wave in punctum plugs! Unique design featureing reservoir indentations to reduce foreign body sensation. Elast™ - a proprietary formulated, hight performance Liquid Silicon Rubber ...
... Attain Prevail's steerable tip, along with various ... obtain the curve you need, when you ... visualization of the cardiac venous anatomy, adjust ... - Adjust curve and reach by ...
... Attain™ Deflectable Catheter - designed to be ... single catheter. Steerablility - Create a variety ... a single, steerable guide catheter. Lock the ... to address each patient's unique anatomy during ...
Medicine Products: